MST1 and neoplasm: However, in some tumor microenvironments, RASSF4 binds to MST1 via its SARAH domain to inhibit the core kinase cascade of the Hippo pathway (MST1–LATS1–YAP), blocking pro-apoptotic signals and promoting apoptosis resistance [37].